31 de mayo de 2016 / 12:47 / hace un año

BRIEF-Hemispherx Biopharma renews sales, marketing, distribution and supply agreement with GP Pharm

May 31 (Reuters) - Hemispherx Biopharma Inc

* Renews sales, marketing, distribution and supply agreement with GP Pharm

* Granted GP Pharm expanded rights to sell ampligen into other Latin American countries based upon certain performance milestones

* Has also granted GP Pharm an option to market alferon n injection trademarked in Argentina as naturaferon

* GP Pharm will be responsible for gaining regulatory approval in Argentina for ampligen, an experimental therapeutic Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below